Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001140361-10-048998
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-09 16:48:39
Reporting Period:
2010-12-07
Filing Date:
2010-12-09
Accepted Time:
2010-12-09 16:48:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1016169 Antares Pharma Inc. AIS Surgical & Medical Instruments & Apparatus (3841) 411350192
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187498 Dario Carrara C/o Antares Pharma, Inc
250 Phillips Blvd, Suite 290
Ewing NJ 08618
Senior Vice President (1) No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-12-07 68,750 $0.85 96,250 No 4 M Direct
Common Stock Disposition 2010-12-07 68,750 $1.51 27,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2010-12-07 68,750 $0.00 68,750 $0.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
631,250 2019-05-13 No 4 M Direct
Footnotes
  1. Represents the exercise of stock options by Dario Carrara,Senior-Vice President of Antares Pharma, Inc., who resigned from his position effective December 31,2010, as disclosed in an 8-K filed September 16, 2010.
  2. Dario Carrara received a grant of options on May 14, 2008, to purchase 82,500 shares of Common Stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options vest in equal quarterly installments over three years.
  3. Not applicable